1. Home
  2. OPTX vs ENLV Comparison

OPTX vs ENLV Comparison

Compare OPTX & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Syntec Optics Holdings Inc.

OPTX

Syntec Optics Holdings Inc.

HOLD

Current Price

$5.51

Market Cap

295.4M

Sector

Finance

ML Signal

HOLD

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$1.10

Market Cap

249.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPTX
ENLV
Founded
1981
2005
Country
United States
Israel
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
295.4M
249.3M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
OPTX
ENLV
Price
$5.51
$1.10
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$13.00
AVG Volume (30 Days)
1.4M
427.3K
Earning Date
11-13-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$27,900,395.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.02
$0.66
52 Week High
$9.15
$2.10

Technical Indicators

Market Signals
Indicator
OPTX
ENLV
Relative Strength Index (RSI) 47.55 56.35
Support Level $5.68 $1.10
Resistance Level $6.49 $1.26
Average True Range (ATR) 1.28 0.08
MACD -0.30 -0.01
Stochastic Oscillator 9.22 42.59

Price Performance

Historical Comparison
OPTX
ENLV

About OPTX Syntec Optics Holdings Inc.

Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Share on Social Networks: